ID: ALA3120682

Max Phase: Preclinical

Molecular Formula: C27H32N2O4

Molecular Weight: 448.56

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccccc1N1CCN(CCCCOc2ccc3c4c(c(=O)oc3c2)CCC4)CC1

Standard InChI:  InChI=1S/C27H32N2O4/c1-31-25-10-3-2-9-24(25)29-16-14-28(15-17-29)13-4-5-18-32-20-11-12-22-21-7-6-8-23(21)27(30)33-26(22)19-20/h2-3,9-12,19H,4-8,13-18H2,1H3

Standard InChI Key:  ZOEBHIRPMYPPES-UHFFFAOYSA-N

Associated Targets(non-human)

Histamine H1 receptor 2054 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Dopamine D3 receptor 1050 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Dopamine D2 receptor 7893 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Serotonin 2a (5-HT2a) receptor 3540 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Serotonin 1a (5-HT1a) receptor 8655 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 448.56Molecular Weight (Monoisotopic): 448.2362AlogP: 4.27#Rotatable Bonds: 8
Polar Surface Area: 55.15Molecular Species: NEUTRALHBA: 6HBD: 0
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.05CX LogP: 4.48CX LogD: 3.74
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.38Np Likeness Score: -0.93

References

1. Chen Y, Lan Y, Wang S, Zhang H, Xu X, Liu X, Yu M, Liu BF, Zhang G..  (2014)  Synthesis and evaluation of new coumarin derivatives as potential atypical antipsychotics.,  74  [PMID:24487191] [10.1016/j.ejmech.2014.01.012]

Source